Raphael Pharmaceutical (RAPH) Enterprise Value (2020 - 2025)
Raphael Pharmaceutical (RAPH) reported Enterprise Value of -$45000.0 for Q4 2025, down 136.84% on a YoY basis from $122142.9 in Q4 2024, and down 1400.0% sequentially from -$3000.0 in Q3 2025.
Raphael Pharmaceutical (RAPH) Enterprise Value (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical (RAPH) has 6 years of Enterprise Value data on file, last reported at -$45000.0 in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 136.84% year-over-year to -$45000.0; the trailing twelve-month figure through Dec 2025 stood at -$45000.0 (down 136.84% YoY), and the FY2025 full-year result was -$45000.0, down 136.84% from the prior year.
- Enterprise Value retreated to -$45000.0 in Q4 2025, from -$3000.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$3000.0 in Q3 2025 to a low of -$299000.0 in Q3 2023.
- A 5-year average of -$113833.3 and a median of -$87000.0 in 2022 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value tumbled 655.26% in 2024 and jumped 92.5% in 2025, its largest moves.
- Tracing RAPH's Enterprise Value over 5 years: stood at -$153000.0 in 2021, then sank by 88.24% to -$288000.0 in 2022, then advanced by 20.14% to -$230000.0 in 2023, then jumped by 91.74% to -$19000.0 in 2024, then sank by 136.84% to -$45000.0 in 2025.
- Business Quant data shows RAPH's Enterprise Value at -$45000.0 in Q4 2025, -$3000.0 in Q3 2025, and -$20000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Raphael Pharmaceutical | 27.37 Mn | 27.33 Mn | - | -45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Mar 31, 2025 | -50,000.00 |
| Dec 31, 2024 | -19,000.00 |
| Sep 30, 2024 | -40,000.00 |
| Jun 30, 2024 | -120,000.00 |
| Mar 31, 2024 | -287,000.00 |
| Dec 31, 2023 | -230,000.00 |
| Sep 30, 2023 | -299,000.00 |
| Jun 30, 2023 | -111,000.00 |
| Mar 31, 2023 | -38,000.00 |
| Dec 31, 2022 | -288,000.00 |
| Sep 30, 2022 | -93,000.00 |
| Jun 30, 2022 | -135,000.00 |
| Mar 31, 2022 | -81,000.00 |
| Dec 31, 2021 | -153,000.00 |
| Sep 30, 2021 | -37,000.00 |
| Dec 31, 2020 | -95,000.00 |